Dr. Charles Marmar, MD

Claim this profile

New York University School of Medicine

Studies Post-Traumatic Stress Disorder
Studies Alcohol-Related Intimate Partner Violence
5 reported clinical trials
6 drugs studied

Affiliated Hospitals

Image of trial facility.

New York University School Of Medicine

Image of trial facility.

NYU Langone Health

Clinical Trials Charles Marmar, MD is currently running

Image of trial facility.

Cannabidiol

for PTSD

This will be a randomized placebo controlled study to test the efficacy of cannabidiol (CBD) as a treatment for symptoms of post-traumatic stress disorder (PTSD). Subjects, 120 in total, will be males and females with PTSD, half of which will have comorbid mild traumatic brain injury (TBI). There will be three study arms, each with 40 subjects: 1) Oral CBD 400 mg daily; 2) Oral CBD 800 mg daily, and 3) Placebo daily. Treatment duration will be 8 weeks. The primary outcome will be change in PTSD symptoms as measured by change in the Clinician-Administered PTSD Scale (CAPS-5) total score.

Recruiting

0 awards

Phase 2

4 criteria

Image of trial facility.

EEG Neurofeedback

for PTSD

The goal of this clinical trial is to learn if training with the Prism system can reduce PTSD symptoms in US military Veterans and civilians with PTSD. Prism is a form of neurofeedback training that uses EEG signals to promote self-regulation of brain function. The main question this study aims to answer is: Does Prism training lead to decreased PTSD symptoms in US Veterans and civilians when used in addition to usual PTSD treatment? Researchers will compare Prism training to a sham training (a look-alike training that does not provide real feedback on brain activity) to see if Prism training decreases PTSD symptoms. Participants will: * Complete two one-hour in-person training sessions a week for about 8 weeks (15 sessions) * Complete two booster training sessions one month and two months after finishing the main training course * Participate in three detailed interviews: one before training, a second after nine weeks of training, and a third one month after the last booster training session (about 20 weeks after the initial visit)

Recruiting

0 awards

N/A

5 criteria

More about Charles Marmar, MD

Clinical Trial Related

5 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical Trials

Treatments Charles Marmar, MD has experience with

  • Cannabidiol
  • Placebo
  • Topiramate
  • Placebos
  • PRISM
  • Prism System

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Charles Marmar, MD specialize in?

Is Charles Marmar, MD currently recruiting for clinical trials?

Are there any treatments that Charles Marmar, MD has studied deeply?

What is the best way to schedule an appointment with Charles Marmar, MD?

What is the office address of Charles Marmar, MD?

Is there any support for travel costs?